Effects of erdosteine on cyclosporine-A–induced hepatotoxicity in rats

References

• Abuja, P. M., Albertini, R. (2001). Methods for monitoring oxidative stresss, lipid peroxidation, and oxidation resistance of lipoproteins. Clin Chim Acta 306:1–17.
   PubMed Web of Science ®Google Scholar
• Actis, G. C., Debernardi-Venon, W., Lagget, M., Marzano, A., Ottobrelli, A., Ponzetto, A., et al. (1995). Hepatotoxicity of intravenous cyclosporine A in patients with acute ulcerative colitis on total parenteral nutrition. Liver 15:320–323.
   PubMedGoogle Scholar
• Aebi, H. (1974). Catalase. In: Bergmeyer, H. U. (Ed.), Methods of enzymatic analysis (pp 673–677). New York: Academic Press.
   Google Scholar
• Andrés, D., Díez-Fernández, C., Zaragoza, A., Alvarez, A., Cascales, M. (2000). Changes in antioxidant defense systems induced by cyclosporine A in cultures of hepatocytes from 2- and 12-month-old rats. Biochem Pharmacol 59:1091–1100.
   PubMed Web of Science ®Google Scholar
• Bianchi, R., Rodella, L., Rezzani, R. (2003). Cyclosporine A upregulates expression of matrix metalloproteinase 2 and vascular endotelial growth factor in rat heart. Int Immunopharmacol 3:427–433.
   PubMed Web of Science ®Google Scholar
• Braga, P. C., Dal Sasso, M., Zuccotti, T. (2000). Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneim Forsch 50:39–46.
   PubMedGoogle Scholar
• Cortas, N. K., Wakid, N. W. (1990). Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443.
   PubMed Web of Science ®Google Scholar
• Dechant, K. L., Noble, S. (1996). Erdosteine. Drugs 52:875–881.
   PubMed Web of Science ®Google Scholar
• Durak, I., Kaçmaz, M., Cimen, M. Y., Büyükkoçak, S., Elgün, S., Oztürk, H. S. (2002). The effect of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues. Transpl Immunol 10:255–258.
   PubMed Web of Science ®Google Scholar
• Durak, I., Ozbek, H., Elgun, S. (2004). Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants. Int Immunopharmacol 4:469–473.
   PubMed Web of Science ®Google Scholar
• Duruibe, V. A., Okonmah, A., Blyden, G. T. (1989). Effect of cyclosporine on rat liver and kidney glutathione content. Pharmacology 39:205–212.
   PubMed Web of Science ®Google Scholar
• Esterbauer, H., Cheeseman, K. H. (1990). Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In: Packer, L., Glazer, A. N. (Eds.), Oxygen radicals in biological systems methods in enzymology (pp 407–421). San Diego, California, USA: Academic Press.
   Google Scholar
• Fadillioglu, E., Erdogan, H. (2003). Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 47:317–322.
   PubMed Web of Science ®Google Scholar
• Galan, A. I., Munoz, M. E., Jimenez, R. (1999). S-adenosylmethionine protects against cyclosporine A–induced alterations in the rat liver plasma membrane fluidity and functions. J Pharmacol Exp Ther 290:774–781.
   PubMed Web of Science ®Google Scholar
• Grieve, D. J., Shah, A. M. (2003). Oxidative stresss in heart failure. More than just damage. Eur Heart J 24:2161–2163.
   PubMed Web of Science ®Google Scholar
• Gutteridge, J. M. C. (1995). Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin Chem 14:1819–1828.
   Google Scholar
• Hagar, H. H. (2004). The protective effect of taurine against cyclosporine A–induced oxidative stresss and hepatotoxicity in rats. Toxicol Lett 15:1335–1343.
   Google Scholar
• Inselmann, G., Lawerenz, H. U., Nellessen, U., Heidemann, H. T. (1994). Enhancement of cyclosporine A–induced hepto- and nephrotoxicity by glutathione depletion. Eur J Clin Invest 24:355–359.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. (2000). Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15:718–724.
   PubMed Web of Science ®Google Scholar
• Kuvandik, G., Duru, M., Nacar, A., Yonden, Z., Helvaci, R., Koc, A., et al. (2008). Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats. Toxicol Pathol 36:714–719.
   PubMed Web of Science ®Google Scholar
• Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186:464–478.
   PubMed Web of Science ®Google Scholar
• Lowry, O. H., Rosebrough, N. J., Farr, A. L. (1951). Protein measuremnet with the Folin-phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Meister, A. (1983). Selective modification of glutathione metabolism. Science 22:472–478.
   Google Scholar
• Moretti, M., Marchioni, C. F. (2007). An overview of erdosteine antioxidant activity in experimental research. Pharmacol Res 55:249–254.
   PubMed Web of Science ®Google Scholar
• Paglia, D. E., Valentina, W. N. (1967). Studies on quantitative and qualitative characterization of erythrocte glutathione peroxidase. J Lab Clin Med 70:158–169.
   PubMed Web of Science ®Google Scholar
• Rezzani, R. (2004). Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochem Cytochem 39:85–128.
   PubMed Web of Science ®Google Scholar
• Sahin, S., Sogut, S., Ozyurt, H., Hüseyin, Ö., Efkan, U., Atilla., I., Ömer, A. (2002). Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111–121.
   Google Scholar
• Sener, G., Sehirli, A. O., Toklu, H. Z., Yuksel, M., Ercan, F., Gedik, N. (2007). Erdosteine treatment attenuates oxidative stresss and fibrosis in experimental biliary obstruction. Pediatr Surg Int 23:233–241.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Oberley, L. W., Li, Y. (1988). A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500.
   PubMed Web of Science ®Google Scholar
• Terzi, A., Iraz, M., Sahin, S., Ilhan, A., Idiz, N., Fadillioglu, E. (2004). Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue. Toxicol Industr Health 20:141–147.
   PubMed Web of Science ®Google Scholar
• Wang, C., Salahudeen, A. K. (1995). Lipid peroxidation accompanies cyclosporine nephrotoxicity: effect of vitamin E. Kidney Int 47:927–934.
   PubMed Web of Science ®Google Scholar
• Yagmurca, M., Bas, O., Mollaoglu, H., Sahin, O., Nacar, A., Karaman, O., et al. (2007). Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Arch Med Res 38:380–385.
   PubMed Web of Science ®Google Scholar
• Yagmurca, M., Fadillioglu, E., Erdogan, H., Ucar, M., Sogut, S., Irmak, M. K. (2003). Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res 48:377–382.
   PubMed Web of Science ®Google Scholar
• Yesildag, A., Ozden, A., Yilmaz, H. R., Uz, E., Agackiran, Y., Yesildag, M., et al. (2009). Erdosteine modulates radiocontrast-induced hepatotoxicity in rat. Cell Biochem Funct 27:142–147.
   PubMed Web of Science ®Google Scholar
• Zachariane, H. (1999). Renal toxicity of long-term cyclosporine. Scand J Rheumatol 28: 65–68.
   PubMed Web of Science ®Google Scholar